Background: Aquasomes are novel trilayered non-lipoidal vesicular nanocarriers that demonstrate structural similarity to ceramic nanoparticles with theranostic activity for diseases like ovarian cancer and antigen delivery.
Objective: The objective of the present article is to highlight the multifaceted potential of aquasomes over other nanocarriers for the treatment of various treatments like hemophilia A, cancer, and hepatitis.
Methods: Aquasomes enter the target cell by modifying the surface chemistry, extending drug release. The solid core of aquasomes provides structural stability whereas their oligomeric coatings protect drugs from dehydration. This vesicular delivery system was successfully utilized for the delivery of acid-labile enzymes, antigens, vaccines, etc. The aquasomes nanocarrier exhibits a larger surface area, volume, and mass ratio that allows the drug to penetrate inside the cells and a prolonged drug release profile. Moreover, aquasomes consist of a high mechanical strength, reduced or no biodegradability during storage, and a good body response that facilitates deeper penetration into capillaries which makes them more special and interesting.
Results: Aquasomes are a potential alternative over other nanocarriers for insulin, antigen, and oxygen delivery.
Conclusion: In the near future, aquasomes-based nano-drug delivery systems can be a fascinating field for research in nanotechnology.
Keywords: Aquasomes; biodegradation; drug delivery; lipid vesicles; nanocarriers; vesicular carriers.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.